ELIXIRGEN THERAPEUTICS, INC.

New Filing
CIK: 0001744333·Biotechnology·DELAWARE·Filed: Feb 18, 2021
Total Offering

$5,499,971

Amount Sold

$4,199,985

Investors

2

First Sale

Feb 2, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
AKIHIRO KO
Related Person
MINORU KO
Related Person
HIROAKI KOBAYASHI
Related Person
Naonori Kurokawa
Related Person
THOMAS WHITE
Related Person
SHAUNA CALLAHAN
Related Person

Company

ELIXIRGEN THERAPEUTICS, INC.

855 N. Wolfe Street, Suite 624

Baltimore, MD, 21205

(443)869-5420

SEC Filing

0001744333-21-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
ELIXIRGEN THERAPEUTICS, INC. Form D Filing — $5,499,971 | FilingFlow